These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 18819480

  • 1. [Preparation of doxorubicin-loaded chitosan polymeric micelle and study on its tissue biodistribution in mice].
    Xu XY, Zhou JP, Li L, Zhang Y, Huo MR, Wang X, Lü L.
    Yao Xue Xue Bao; 2008 Jul; 43(7):743-8. PubMed ID: 18819480
    [Abstract] [Full Text] [Related]

  • 2. [Preparation of paclitaxel-loaded chitosan polymeric micelles and influence of surface charges on their tissue biodistribution in mice].
    Huo MR, Zhou JP, Wei Y, Lü L.
    Yao Xue Xue Bao; 2006 Sep; 41(9):867-72. PubMed ID: 17111835
    [Abstract] [Full Text] [Related]

  • 3. [Solubilizing and sustained-releasing abilities and safety preliminary evaluation for paclitaxel based on N-octyl-O, N-carboxymethyl chitosan polymeric micelles].
    Huo MR, Zhang Y, Zhou JP, Lü L, Liu H, Liu FJ.
    Yao Xue Xue Bao; 2008 Aug; 43(8):855-61. PubMed ID: 18956780
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles.
    Hu FQ, Liu LN, Du YZ, Yuan H.
    Biomaterials; 2009 Dec; 30(36):6955-63. PubMed ID: 19782395
    [Abstract] [Full Text] [Related]

  • 5. PEG conjugated N-octyl-O-sulfate chitosan micelles for delivery of paclitaxel: in vitro characterization and in vivo evaluation.
    Qu G, Yao Z, Zhang C, Wu X, Ping Q.
    Eur J Pharm Sci; 2009 May 12; 37(2):98-105. PubMed ID: 19429416
    [Abstract] [Full Text] [Related]

  • 6. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM, Li YJ, Qiu LY, Jin Y.
    J Pharm Pharmacol; 2009 Jun 12; 61(6):713-9. PubMed ID: 19505361
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo study of Gal-OS self-assembled nanoparticles for liver-targeting delivery of doxorubicin.
    Guo H, Zhang D, Li T, Li C, Guo Y, Liu G, Hao L, Shen J, Qi L, Liu X, Luan J, Zhang Q.
    J Pharm Sci; 2014 Mar 12; 103(3):987-93. PubMed ID: 24549734
    [Abstract] [Full Text] [Related]

  • 8. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A, Chen J, Liu Y, Deng S, Wu Z, Huang Y, Ping Q.
    Drug Dev Ind Pharm; 2009 Nov 12; 35(11):1348-55. PubMed ID: 19832635
    [Abstract] [Full Text] [Related]

  • 9. [Effect of diameter of adriamycin polybutylcyanoacrylate nanoparticles on liver targeting].
    Shen LF, Wang X, Wang C, Zhao K, Liu XJ, Shen HJ.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct 12; 31(5):732-6, 741. PubMed ID: 17062941
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. DNA/chitosan nanocomplex as a novel drug carrier for doxorubicin.
    Cheng X, Zhang F, Zhou G, Gao S, Dong L, Jiang W, Ding Z, Chen J, Zhang J.
    Drug Deliv; 2009 Apr 12; 16(3):135-44. PubMed ID: 19514973
    [Abstract] [Full Text] [Related]

  • 12. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
    Cui J, Li C, Guo W, Li Y, Wang C, Zhang L, Zhang L, Hao Y, Wang Y.
    J Control Release; 2007 Apr 02; 118(2):204-15. PubMed ID: 17239468
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Preparation of itraconazole-loaded liposomes coated by carboxymethyl chitosan and its pharmacokinetics and tissue distribution.
    Wang J, Huang G.
    Drug Deliv; 2011 Nov 02; 18(8):631-8. PubMed ID: 22111976
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Targeting therapy of magnetic doxorubicin liposome in nude mice bearing colon cancer].
    Zhou PH, Yao LQ, Qin XY, Shen XZ, Liu YS, Lu WY, Yao M.
    Zhonghua Yi Xue Za Zhi; 2003 Dec 10; 83(23):2073-6. PubMed ID: 14703420
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
    Zhang C, Qu G, Sun Y, Wu X, Yao Z, Guo Q, Ding Q, Yuan S, Shen Z, Ping Q, Zhou H.
    Biomaterials; 2008 Mar 10; 29(9):1233-41. PubMed ID: 18093646
    [Abstract] [Full Text] [Related]

  • 18. Enhanced circulation time and antitumor activity of doxorubicin by comblike polymer-incorporated liposomes.
    Han HD, Lee A, Hwang T, Song CK, Seong H, Hyun J, Shin BC.
    J Control Release; 2007 Jul 31; 120(3):161-8. PubMed ID: 17524514
    [Abstract] [Full Text] [Related]

  • 19. Biodistribution of doxorubicin-alkylated poly(L-lysine citramide imide) conjugates in an experimental model of peritoneal carcinomatosis after intraperitoneal administration.
    Colombo PE, Boustta M, Poujol S, Pinguet F, Rouanet P, Bressolle F, Vert M.
    Eur J Pharm Sci; 2007 May 31; 31(1):43-52. PubMed ID: 17383164
    [Abstract] [Full Text] [Related]

  • 20. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery.
    Tian Q, Zhang CN, Wang XH, Wang W, Huang W, Cha RT, Wang CH, Yuan Z, Liu M, Wan HY, Tang H.
    Biomaterials; 2010 Jun 31; 31(17):4748-56. PubMed ID: 20303163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.